Navigation Links
Men with prostate cancer avoid radiation due to misconceptions

Negative perceptions about radiation therapy can strongly influence a prostate cancer patient's choice to avoid external beam radiation therapy, even though studies have proven the treatment to be as safe and effective as other treatments for the disease, including surgery, according to a study presented November 5, 2006, at the American Society for Therapeutic Radiology and Oncology's 48th Annual Meeting in Philadelphia.

"The study shows that patients base their treatment choice not only on technical information, but also on cultural and personal prejudices," said Riccardo Valdagni, M.D., an author of the study and head of the Prostate Programme at the Fondazione IRCCS Istituto Nazionale dei Tumori in Milan, Italy. "It's important for patients to express their fears about radiation treatment to their doctors and for doctors to consider these worries and address any misconceptions about this therapy so that patients can make the best, most informed decision about their treatment."

Men with prostate cancer often choose between external beam radiation therapy, radiation seed implants and surgery to treat their cancer. During external beam radiation, a beam of radiation, or X-ray, is directed through the skin to the cancer and the immediate surrounding area to kill the cancer. To minimize side effects, radiation is given five days a week for several weeks. Many men with prostate cancer choose external beam radiation over other treatments because it is non-invasive, has a short recovery period and often helps men preserve their sexual and urinary function.

However, Dr. Valdagni's study shows that some men with prostate cancer have definite fears about radiation treatment, with the greatest worries related to false beliefs on how the X-rays would affect them. For example, some patients think that radiation cannot be controlled because it is invisible, that it will harm surrounding unprotected organs and that it is dangerous for family members t o physically be near them when undergoing radiation treatment. Patients also said that the terminology used in radiation therapy, such as the term "hitting the target," evoked feelings more related to war than to a cure. In addition, while some patients experienced technology as reassuring, many others felt that the technologically advanced computer equipment used during radiation treatment provoked anxiety.

The study was carried out by a multidisciplinary team of doctors (urologists, radiation oncologists, medical oncologists and psychologists) at the Milan National Cancer Institute Prostate Cancer Program from March 2005 to March 2006. The team interviewed 257 men with prostate cancer to find out their perceptions about radiation therapy.
'"/>

Source:American Society for Therapeutic Radiology and Oncology


Related biology news :

1. Mitochondrial DNA mutations play significant role in prostate cancer
2. Weizmann Institute scientists develop a new approach for directing treatment to metastasized prostate cancer in the bones.
3. Test for early detection of prostate cancer shows promise
4. U-M researchers identify new blood test for prostate cancer
5. U-M scientists say fused genes trigger the development of prostate cancer
6. Virus chip detects new virus in prostate tumors
7. Human prostate grown from embryonic stem cells
8. Curry and cauliflower could halt prostate cancer
9. Macrophage signaling may affect hormone resistance in prostate tumors
10. Markers of gene, protein, or micro-RNA activity predict outcome in prostate and colorectal cancers
11. Vegetables inhibit growth of prostate cancer in mice with human tumors

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/17/2016)... announces that it has just released a new white paper authored by Zettar that ... speed data transfer storage solutions. Photo - http://photos.prnewswire.com/prnh/20161116/440463 ... ... ... Setting up a high performance computing or HPC system can be a ...
(Date:11/15/2016)... Nov 15, 2016 Research and Markets has ... to 2021" report to their offering. ... ... Billion by 2021 from USD 6.21 Billion in 2016, growing at ... Growth of the bioinformatics market is driven by the growing demand ...
(Date:6/27/2016)... Research and Markets has announced the addition of the ... The report forecasts the biometrics ... a CAGR of 12.28% during the period 2016-2020. ... with inputs from industry experts. The report covers the market landscape ... includes a discussion of the key vendors operating in this market. ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... December 01, 2016 , ... DrugDev believes ... standardization and a beautiful technology experience. All three tenets were on display at the ... trial leaders from over 40 sponsor, CRO and site organizations to discuss innovation and ...
(Date:12/2/2016)... The immunohistochemistry (IHC) market is projected to reach ... during the forecast period of 2016 to 2021 dominated by immunohistochemistry ... the largest share of immunohistochemistry (IHC) market, by end user.   ... , , ... across 225 pages, profiling 10 companies and supported with 181 tables ...
(Date:11/30/2016)... /PRNewswire/ - Portage Biotech Inc. ("Portage" or "the Company") ... to announce the formation of EyGen, Ltd. a ... assets through proof of concept. EyGen,s lead asset ... Pharmaceuticals Limited and being developed for topical ophthalmic ... segment diseases. This agent has the potential to ...
(Date:11/30/2016)... and BEIJING , Nov. 30, ... commercial provider of genomic services and solutions with cutting ... that it has completed a USD $75 Million [515 ... Co., Ltd.,s CMB International Capital Management ( Shenzhen ... Management Co., Ltd. ("SDIC Innovation") and Shanghai Sigma Square ...
Breaking Biology Technology: